Global childhood vaccination rates rose slightly in 2025, with 90% of infants receiving at least one dose of the DTP vaccine, according to data from the World Health Organization (WHO) and UNICEF. Despite this, 13.5 million children remain “zero-dose,” leaving millions vulnerable to preventable diseases amid funding cuts and active conflicts. The Gap Between First … Read more
The U.S. Food and Drug Administration (FDA) has officially accepted for review Sandoz’s applications for two generic versions of tirzepatide, the active ingredient in Eli Lilly’s popular weight-loss and diabetes treatments. This regulatory step marks a significant move toward potential market competition for Mounjaro and Zepbound ahead of the expiration of Eli Lilly’s U.S. patents … Read more
Roche has launched its Axelios gene sequencer, a new platform designed to perform large-scale DNA and RNA analysis, marking the company’s attempt to compete with industry leader Illumina. Roche aims to sell about 100 machines within the first year, targeting academic and research institutions to build a foundation for long-term growth in the $7.3 billion … Read more
Merck KGaA has announced an $11.3 billion agreement to acquire U.S.-based Bio-Techne, marking the German pharmaceutical giant’s largest acquisition since 2014. The deal, which offers $73 per share—a 24% premium over the closing price on Wednesday—is designed to bolster Merck’s life sciences division by integrating Bio-Techne’s extensive portfolio of research reagents, proteins, and analytical instruments … Read more
The U.S. government has begun shipping stockpiled doses of an experimental antibody drug, MBP134, from Mapp Biopharmaceutical to the Democratic Republic of Congo to combat a widening Bundibugyo Ebola outbreak. According to the U.S. Department of Health and Human Services, this shift in policy marks the first time Washington has released the treatment for clinical … Read more
From Terminal to Chronic: The New Era of Precision Oncology For decades, a cancer diagnosis often felt like a binary outcome. Today, that narrative is shifting. Thanks to a deeper understanding of the human genome, we are entering an era where cancer is increasingly managed as a chronic, long-term condition rather than an immediate death … Read more
The Antibiotic Crisis: Why Europe’s Fight Against Cheap Imports Matters The pharmaceutical industry is facing a quiet, yet critical, supply chain emergency. Recent moves by major players like Sandoz to file anti-dumping complaints against Chinese antibiotic imports signal a growing realization: the era of relying on ultra-low-cost, foreign-manufactured medicine may be coming to a dangerous … Read more
The New Era of Obesity Treatment: France’s Pivot Toward Reimbursement The landscape of weight-loss management is shifting beneath our feet. As France prepares to offer state-backed reimbursement for high-profile injectable medications like Wegovy and Mounjaro, the medical community is bracing for a massive shift in how society approaches metabolic health. View this post on Instagram … Read more